FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
There is no source of health expertise when someone is sold peptides. Injectors are left to learn from forums, influencers, ...
“...the policy addresses concerns that extend beyond common political divisions,” Beene said.
Although nearly half of all U.S. hospitals participate in it, few Americans have heard of the 340B Drug Pricing Program. The ...
Eli Lilly shares are rallying to a new record high on Thursday after the drugmaker delivered another beat-and-raise quarter, ...
Hospitals are beginning to give AI systems something more consequential than the ability to generate text: permission to act.
A clearly superior clinical profile, reasonable pricing and easy access has helped a handful of recently approved therapies ...
The Republican candidate running to be Iowa’s next governor says members of his own family benefit from the use of medical ...
On October 14, 2026, the U.S. Food and Drug Administration (FDA) released a white paper introducing its Rare Disease Framework Initiative, calling ...
President Donald J. Trump is delivering an America First surge of manufacturing, energy, agriculture, semiconductor, shipbuilding, and national security ...
Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic ...
As California is facing a shortage of credentialed teachers, UC Davis has launched a new program to help students earn both a teaching credential and a master's degree in just one calendar year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results